🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
SBRT, atezolizumab, and bevacizumab have different mechanisms of action and...
Status
Unknown
Location
Institute of Liver & Biliary Sciences
Start Date
2024-02-05
Trial ID
NCT06244446
Treatments Being Tested
The goal of this clinical trial is to learn if locoregional therapy and imm...
Status
Recruiting
Location
London Health Sciences Centre
Start Date
2024-12
Trial ID
NCT06725121
Treatments Being Tested
Patients with PVTT involvement is a significant healthcare burden as they a...
Status
Recruiting
Location
Department of Clinical Oncology, Prince of Wales Hospital
Start Date
2025-07-10
Trial ID
NCT06823375
Treatments Being Tested
To determine the efficacy and safety of atezolizumab-bevacizumab combinatio...
Status
Recruiting
Location
Yongin Severance Hospital
Start Date
2024-05-28
Trial ID
NCT06595108
Treatments Being Tested
Atezolizumab (anti-programmed death-ligand 1; anti-PD-L1) in conjunction wi...
Status
Recruiting
Location
Chang Gung Memorial Hospital at Linkou
Start Date
2024-03-30
Trial ID
NCT06339424
Treatments Being Tested
This phase III trial compares the effect of immunotherapy (IO) with stereot...
Status
Recruiting
Location
Alta Bates Summit Medical Center-Herrick Campus
Start Date
2026-02-26
Trial ID
NCT07166406
This research study is evaluating the safety and tolerability of the drugs ...
Status
Recruiting
Location
Massachusetts General Hospital Cancer Center
Start Date
2022-08-23
Trial ID
NCT05096715
Treatments Being Tested
First-line immunotherapy-based standard of care and local ablative treatmen...
Status
Recruiting
Location
Institut de Radiothérapie du Sud de l'Oise
Start Date
2025-09-09
Trial ID
NCT06840782
Treatments Being Tested
This is An Open-label, Single-arm Exploratory Study to determine the effica...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2022-01-12
Trial ID
NCT05396937
Treatments Being Tested
A phase I dose escalation and pharmacodynamic study of repeated dose stereo...
Status
Recruiting
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2022-09-01
Trial ID
NCT05488522
Treatments Being Tested